In cancer research, sclareol not only showed an anticancer effect, but also had the ability to target the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathway [28], showing that sclareol can modulate the ERK/p38 signaling pathway. Here, WNK2 is linked to cancer.